Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant [Yahoo! Finance]
Envoy Medical, Inc. - Class A (COCH)
Company Research
Source: Yahoo! Finance
White Bear Lake, Minnesota--(Newsfile Corp. - December 18, 2025) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that its pivotal clinical study for the investigational fully implanted Acclaim® cochlear implant has achieved yet another milestone by reaching the midway point of the study's full enrollment target. Despite holiday scheduling and year-end operating room constraints, enrollment is progressing at a steady pace. Sites report actively screening numerous potential candidates. Full enrollment is currently on track to be completed within the first half of Q1 2026. "Reaching the midway point of the study's enrollment is another strong indication that our pivotal study continues to move forward efficiently," said Brent Lucas, Chief Executive Officer of Envoy Medical. "Even in a season that traditionally makes scheduling difficult, the investigational sites and our i
Show less
Read more
Impact Snapshot
Event Time:
COCH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COCH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COCH alerts
High impacting Envoy Medical, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
COCH
News
- Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- Envoy Medical (NASDAQ:COCH) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=COCH&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen<MarketBeat
- Envoy Medical (NASDAQ:COCH) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- AI & Technology Virtual Investor Conference: Presentations Now Available for Online ViewingGlobeNewswire
- AI & Technology Virtual Investor Conference Agenda Announced for October 28thGlobeNewswire
COCH
Sec Filings
- 12/18/25 - Form S-1
- 12/16/25 - Form 8-K
- 12/10/25 - Form 4
- COCH's page on the SEC website